New: Evolving the Heatmap: Dow Jones, Nasdaq 100, Russell 2000, and More

Predictive Oncology Inc.

Contributing Author

Recent Articles by Predictive Oncology Inc.

Sep-29	Predictive Oncology Inc. Announces Private Placements of $344 Million to Initiate a Digital Asset Treasury Strategy Focused on Aethir (ATH) Tokens POAI GlobeNewswire
Sep-25	Predictive Oncology Announces 1-for-15 Reverse Stock Split POAI GlobeNewswire
Sep-04	Predictive Oncology and Every Cure Announce a Strategic Collaboration to Pursue Drug Repurposing for Cancer Patients POAI GlobeNewswire
Aug-14	Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update POAI GlobeNewswire
Jul-15	Predictive Oncology Issues Shareholder Letter: Well Financed to Support Expanded U.S. Availability and E.U. Launch of ChemoFx and Pursuit of Other High-Value AI-Driven Drug Discovery and Development Opportunities POAI GlobeNewswire
Jul-08	Predictive Oncology Announces $10M Share Purchase Agreement in Partnership with Yorkville Advisors to Advance AI-Driven Drug Discovery and Repurposing POAI GlobeNewswire
Jun-12	Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp POAI GlobeNewswire
May-27	Court Denies Renovaro Motion for an Expedited Trial in July POAI GlobeNewswire
May-22	AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition POAI GlobeNewswire
May-20	Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: AI-Driven Biomarker and Drug Discovery for Precision Health" POAI GlobeNewswire
May-15	Predictive Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update POAI GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.